Corcept Therapeutics
(NASDAQ:CORT)
$25.28
-0.28[-1.10%]
At close: Nov 30(Delayed 15-Minutes)
Get Real Time Here
$25.28
After Hours: 4:07PM EDT
Day Range24.84 - 25.7252 Wk Range15.83 - 30.14Open / Close25.68 / 25.28Float / Outstanding69.9M / 107.6M
Vol / Avg.821.6K / 558.5KMkt Cap2.7BP/E25.5450d Avg. Price26.64
Div / Yield-Payout Ratio-Total Float69.9MEPS0.32

Corcept Therapeutics Stock (NASDAQ:CORT), Quotes and News Summary

Corcept Therapeutics Stock (NASDAQ: CORT) stock price, news, charts, stock research, profile.

Loading...
Day Range24.84 - 25.7252 Wk Range15.83 - 30.14Open / Close25.68 / 25.28Float / Outstanding69.9M / 107.6M
Vol / Avg.821.6K / 558.5KMkt Cap2.7BP/E25.5450d Avg. Price26.64
Div / Yield-Payout Ratio-Total Float69.9MEPS0.32
Newsfile - Sep 14, 2022, 5:44PM
Newsfile - Aug 31, 2022, 5:44PM
Newsfile - Aug 28, 2022, 8:16AM
Newsfile - Aug 17, 2022, 5:44PM
Newsfile - Aug 14, 2022, 8:16AM
Newsfile - Aug 3, 2022, 5:44PM
Newsfile - Jul 31, 2022, 8:16AM
Newsfile - Jul 20, 2022, 5:44PM
Newsfile - Jul 13, 2022, 5:44PM
Seeking Alpha - Nov 1, 2022, 5:35PM
InvestorPlace - Oct 17, 2022, 6:45AM
Seeking Alpha - Sep 6, 2022, 7:01AM
Seeking Alpha - Aug 2, 2022, 5:35PM
StockNews - Jul 15, 2022, 8:01PM
InvestorPlace - Jul 15, 2022, 7:50AM
Seeking Alpha - Jul 14, 2022, 1:14AM
Sector: Health Care.Industry: Pharmaceuticals
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-02-14
REV
Q3 2022Est.ActualSurprise
EPS0.2200.300 0.0800
REV107.590M101.728M-5.862M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Corcept Therapeutics (CORT) stock?

A

You can purchase shares of Corcept Therapeutics (NASDAQ: CORT) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Corcept Therapeutics's (CORT) competitors?

A

Other companies in Corcept Therapeutics’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Novartis (NYSE:NVS) and Pfizer (NYSE:PFE).

Q

What is the target price for Corcept Therapeutics (CORT) stock?

A

The latest price target for Corcept Therapeutics (NASDAQ: CORT) was reported by HC Wainwright & Co. on Thursday, August 4, 2022. The analyst firm set a price target for 33.00 expecting CORT to rise to within 12 months (a possible 30.54% upside). 4 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Corcept Therapeutics (CORT)?

A

The stock price for Corcept Therapeutics (NASDAQ: CORT) is $25.28 last updated November 30, 2022, 9:00 PM UTC.

Q

Does Corcept Therapeutics (CORT) pay a dividend?

A

There are no upcoming dividends for Corcept Therapeutics.

Q

When is Corcept Therapeutics (NASDAQ:CORT) reporting earnings?

A

Corcept Therapeutics’s Q4 earnings are confirmed for Tuesday, February 14, 2023.

Q

Is Corcept Therapeutics (CORT) going to split?

A

There is no upcoming split for Corcept Therapeutics.

Q

What sector and industry does Corcept Therapeutics (CORT) operate in?

A

Corcept Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.